United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

18 Apr 2019
Change (% chg)

$0.54 (+0.88%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Baker, Felix 

Dr. Felix J. Baker, Ph.D., serves as Independent Director of the Company. Dr. Baker’s firm manages long-term investment funds, focused on publicly traded life sciences companies, for major university endowments and foundations. Dr. Baker’s career as a fund-manager began in 1994 when he and his brother co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker is also a director of Seattle Genetics, Inc., where he serves as lead independent director, and Alexion Pharmaceuticals, Inc. Dr. Baker served as a director of Synageva BioPharma Corp. from October 2000 until its acquisition in June 2015. Dr. Baker holds a B.S. and Ph.D. in Immunology from Stanford University, where he also completed two years of medical school.

Basic Compensation

Total Annual Compensation, USD 20,000
Restricted Stock Awards, USD 40,000
Long-Term Incentive Plans, USD --
All Other, USD 132,727
Fiscal Year Total, USD 192,727

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits


Gordon Cole


Steven Shak


Phillip Febbo


Laura Kammeyer


Frederic Pla

As Of  30 Dec 2017